Skip to main content

February 5, 2019

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research

This FOA solicits grant applications proposing exploratory research projects focused on early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research. R21 clinical trials not allowed. Award Amount: NCI intends to commit $4,200,000 towards approximately 17 awards. The total project period request may not exceed 3 …